Daniel Kim

ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy

D. Mankoff, Lucy Hanna, K. Schmainda, 2018, PloS one.

MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastoma

B. Rosen, Jayashree Kalpathy-Cramer, Y. Yen, 2021, Neuro-oncology advances.

Myo-Inositol Levels Measured with MR Spectroscopy Can Help Predict Failure of Antiangiogenic Treatment in Recurrent Glioblastoma.

Y. Yen, T. Batchelor, Julian He, 2021, Radiology.